TP53 and cancer: The plausibility of these additional effects has been observed in Fancd2/Tp53, Fancc/Tp53 and Fanca/Tp53 double knock-out mice: all have significantly lower rates of cancer-free survival than either single mutant or control mice for epithelial as well as non-epithelial tumors [54,55,75].